Phiyen Vutran

Phiyen Vutran practices at Contour Dermatology And Cosmetic Surgery Center in Rancho Mirage, California.

Phiyen Vutran's NPI, 1427605567, was assigned on August 22, 2019.

Phiyen Vutran's primary practice is Contour Dermatology and Cosmetic Surgery Center, at 42600 Mirage Rd Suite A1 Suite A1, Rancho Mirage, CA 92270-4127. The practice phone is (760) 423-4000.

Phiyen Vutran's primary practice is Contour Dermatology And Cosmetic Surgery Center in Rancho Mirage, California. The medical group on file is Contour Dermatology and Cosmetic Surgery Center. Dmand AI also links Phiyen Vutran to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Phiyen Vutran practices. Vendor and product names are available with a free account.

Physician assistant is Phiyen Vutran's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, scalp rash, shingles, skin cyst and skin discoloration among the conditions Phiyen Vutran treats.

CMS data shows 6,033 Medicare services from Phiyen Vutran across 24 procedure codes in 2024, for 1,020 Medicare patients. Medicare paid $291,064 for them. Every service was in an office.

CMS counts 1,020 Medicare patients who saw Phiyen Vutran in 2024. The largest group is 65 to 74, with 451 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Phiyen Vutran's median patient age at 70, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Phiyen Vutran for performance year 2024, reported as part of a group. Phiyen Vutran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Phiyen Vutran as offering telehealth.

CMS Open Payments shows 52 general payments to Phiyen Vutran from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $812.